Latigo Biotherapeutics
LTGO
15.52
-0.74
-4.55%
Latigo Biotherapeutics
US · LTGO
#3230 by market cap
Listed 2026
15.52
-0.74
-4.55%
Live - 5344 symbols - heartbeat 273s ago
· 2026-10-07 19:54
After-hours
15.89
+2.38%
- Market cap
- 1.03B
- P/E (TTM)i
- -9.26
- P/Bi
- -3.73
- EPSi
- -1.82
- Div yieldi
- 0.00%
- 52W posi
- 2%
Reader sentiment
Are you bullish or bearish on LTGO?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Goldman Sachs Initiates Latigo Biotherapeutics(LTGO.US) With Buy Rating, Announces Target Price $73Market Newswire · 2026/9/1
-
Goldman Sachs Maintains Latigo Biotherapeutics(LTGO.US) With Buy Rating, Maintains Target Price $73Market Newswire · 2026/9/4
-
Guggenheim Initiates Latigo Biotherapeutics(LTGO.US) With Buy Rating, Announces Target Price $50Market Newswire · 2026/9/2
-
Jefferies Initiates Latigo Biotherapeutics(LTGO.US) With Buy Rating, Announces Target Price $50Market Newswire · 2026/9/2
-
Analysts Offer Insights on NA Companies: Latigo Biotherapeutics, Inc. (LTGO), Golar LNG (GLNG) and Mobility Global Inc (MBGL)TipRanks · 2026/9/2
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.